3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow TD-9855: new trials by email Literature Review of TD-9855 trials Research Report on TD-9855
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855 Ampreloxetine - Symptomatic Neurogenic Orthostatic Hypertension, nOH | Phase 1 | Completed | Theravance Biopharma | 31 | 2020-01-13 | 2021-09-08 |
| Drug-Drug Interaction (DDI) Study for TD-9855 TD-9855, Fluvoxamine, Itraconazole - Drug Drug Interaction (DDI) | Phase 1 | Completed | Theravance Biopharma | 41 | 2018-02-28 | 2021-01-14 |
| TD-9855 Mass Balance Study TD-9855 - ADHD, Fibromyalgia | Phase 1 | Completed | Theravance Biopharma | 6 | 2013-10-01 | 2021-01-19 |
Attention Deficit Disorder with Hyperactivity (1) · Fibromyalgia (1) · Smoking (1)
United States (3)